Related Experiment Videos
[Diabetes and estrogens-gestagens (author's transl)]
MMW, Munchener Medizinische Wochenschrift
|May 13, 1977
Summary
Oral contraceptives slightly affect glucose tolerance in normal women but can worsen diabetes in those with a predisposition. Careful monitoring or discontinuation is crucial for diabetic patients using these medications.
Area of Science:
- Endocrinology
- Reproductive Health
- Metabolic Disorders
Background:
- Oral contraceptives (OCs) containing estrogens/gestagens (OE-P) are widely used.
- The impact of OE-P on glucose metabolism, particularly in women with diabetes or predisposition, requires careful consideration.
Purpose of the Study:
- To evaluate the effect of oral contraceptives on glucose tolerance in women.
- To assess the risks and benefits of OE-P in women with latent or manifest diabetes.
Main Methods:
- The abstract does not specify the methods used.
- The study likely involved observational analysis or clinical assessments of glucose tolerance.
Main Results:
- Normal women show minimal to no disturbance in glucose tolerance with OE-P.
- Women with hereditary diabetic taint or gestational diabetes complications experience intensified diabetogenic effects.
- OE-P can precipitate irreversible manifest diabetes in latent diabetes cases.
- Manifest diabetes requires careful OE-P supervision, often necessitating increased antidiabetic medication dosages.
Conclusions:
- OE-P are contraindicated in latent diabetes due to the risk of irreversible progression.
- Careful monitoring of blood sugar, lipids, and vascular health is essential when OE-P are used in manifest diabetes.
- Discontinuation of OE-P is necessary if diabetes is not adequately stabilized.
- Reproductive decisions for young women with diabetes should consider disease progression and vascular complications.